Here, we characterize BTBD1 (9) expression in CRC, assess its associations with clinicopathological features and prognosis, and use multi-omics analyses to explore its functional roles in tumor progression and immune infiltration-with the goal of evaluating BTBD19 as a potential CRC biomarker. This evidence concerns the gene BTBD19 and colorectal carcinoma.